VF
AXSM icon

Virtu Financial’s Axsome Therapeutics AXSM Stock Holding History

Virtu Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,573
Closed -$2.84M – 1634
2025
Q4 		$2.84M Buy
+15,573
New +$2.17M 0.11% 97
2025
Q2 		– Sell
-7,986
Closed -$931K – 1449
2025
Q1 		$931K Buy
+7,986
New +$910K 0.05% 296
2023
Q4 		– Sell
-13,686
Closed -$956K – 1565
2023
Q3 		$956K Sell
13,686
-15,893
-54% -$1.19M 0.1% 185
2023
Q2 		$2.13M Buy
29,579
+23,508
+387% +$1.73M 0.16% 99
2023
Q1 		$374K Buy
+6,071
New +$399K 0.04% 450
2022
Q4 		– Sell
-9,466
Closed -$422K – 1595
2022
Q3 		$422K Buy
9,466
+1,111
+13% +$55.5K 0.04% 475
2022
Q2 		$320K Buy
+8,355
New +$264K 0.03% 553
2021
Q4 		– Sell
-20,292
Closed -$669K – 1706
2021
Q3 		$669K Buy
+20,292
New +$791K 0.06% 343
2021
Q2 		– Sell
-5,940
Closed -$336K – 1509
2021
Q1 		$336K Buy
+5,940
New +$418K 0.02% 749
2020
Q4 		– Sell
-12,320
Closed -$878K – 1428
2020
Q3 		$878K Buy
12,320
+6,336
+106% +$494K 0.15% 147
2020
Q2 		$492K Buy
+5,984
New +$461K 0.06% 380
2018
Q3 		– Sell
-18,609
Closed -$60K – 1535
2018
Q2 		$60K Buy
+18,609
New +$57.7K ﹤0.01% 1727

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's AXSM Position: Q1 2026 in Review

Virtu Financial sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 15,573 shares — an estimated $2.84M sold.

Virtu Financial first reported a position in AXSM in Q2 2018 and held it in 12 quarters. The position peaked at $2.84M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Virtu Financial reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 15,573 Axsome Therapeutics shares in Q1 2026, an estimated $2.84M.
  • Virtu Financial first reported a position in Axsome Therapeutics in Q2 2018 and held it in 12 quarters.
  • Virtu Financial's Axsome Therapeutics position peaked at $2.84M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.